| |
| Names | |
|---|---|
| IUPAC name
(8β)-1-(1,2-Dimethylcyclobutane-1-carbonyl)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide
| |
| Other names
1-(1,2-Dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide
| |
| Identifiers | |
3D model (JSmol)
|
|
| |
| Properties | |
| C27H35N3O2 | |
| Molar mass | 433.596 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
1D-LSD (1-(1,2-dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide) is a psychotropic substance and a research chemical that has potential psychedelic effects. It is believed to be a prodrug for LSD and has replaced 1V-LSD in Germany after 1V-LSD became covered by the German NpSG law in 2022.[citation needed] It is also available as tartrate and liquid.[citation needed]
Legality[edit]
Germany[edit]
Currently 1D-LSD is neither covered by the German BTMG nor the NpSG law and can thus be sold for research purposes.[1] The German expert committee for narcotics has, in a meeting on December 4, 2023, suggested to add 1D-LSD to the NpSG.[2]
Austria[edit]
According to the current legal situation, 1D-LSD is neither explicitly mentioned in the Narcotic Drugs Ordinance nor in the Psychotropic Substances Ordinance (SV/PV), thus it is neither to be classified as a narcotic drug in the sense of the SV nor as a psychotropic substance in the sense of the PV.
See also[edit]
References[edit]
- ^ "NpSG - nichtamtliches Inhaltsverzeichnis". www.gesetze-im-internet.de (in German). Retrieved 2023-08-29.
- ^ "Sachverständigenausschuss für Betäubungsmittel nach § 1 Abs. 2 BtMG und Neue-psychoaktive-Stoffe nach § 7 NpSG". www.bfarm.de (in German). Retrieved 2024-01-15.